Empowering the Voice of Kansas Pharmacy

Log in

Latest News

Pharmacy News & Notes

Share your news with KPhA! Submit an announcement.

  • 04/05/2021 12:42 PM | Anonymous member (Administrator)

    Create an environment where all employees have a voice and feel empowered to speak up when they see something is not right. For more information, or to get your Medication Safety and Continuous Quality Improvement (CQI) program started, go to https://medicationsafety.org/sign-up.php or give APMS® a call at (866)365-7472!

  • 04/02/2021 4:05 PM | Anonymous member (Administrator)

    Kansas lawmakers are moving closer to a vote on legalizing medical cannabis in the state. For the first time, a bill to do that passed out of committee on Monday (March 29) and is on the way to the Full House chamber. The Federal and State Affairs committee in the Kansas House passed the bill in a gut-and-go of Senate Bill 158 Monday morning. Kansas is one of only three states without some form of a state cannabis program.

    Read More from KWCH

  • 04/01/2021 8:27 PM | Anonymous member (Administrator)

    KPhA recently offered APhA's Pharmacy-based Immunization Delivery Certificate Course and we are curious if there is enough interest to offer another round of this training for pharmacists.

    If you are a pharmacist and would like to become an APhA-certified immunizer, please pre-register by April 15. If there is enough interest, we will work with our faculty to get it on the calendar.

    Pre-Enroll Today!

  • 04/01/2021 9:51 AM | Anonymous member (Administrator)

    WASHINGTON -- The Human Rights Campaign (HRC) Foundation, the educational arm of the nation’s largest lesbian, gay, bisexual, transgender and queer (LGBTQ) civil rights organization, and the American Pharmacists Association (APhA) released a new guide for pharmacies on transgender and gender-diverse inclusion, “Providing Inclusive Care and Services for the Transgender and Gender Diverse Community: A Pharmacy Resource Guide.”

    The guide, released on International Transgender Day of Visibility, serves as an educational tool and a resource to pharmacists and pharmacy staff on how to be inclusive to transgender, non-binary and gender-diverse patients.

    “Transgender, non-binary and gender-diverse people everywhere deserve competent care when visiting any health care provider, including pharmacies,” said Tari Hanneman, HRC Director, Health & Aging Program. “This resource, released today to mark International Transgender Day of Visibility, will help pharmacists and pharmacy staff provide trans-competent and trans-inclusive care to all of their patients. The Human Rights Campaign is proud to partner with the American Pharmacists Association on this critical resource.”

    Read more and get the guide

  • 03/18/2021 1:20 PM | Anonymous member (Administrator)

    Click here to view the Kansas House Insurance and Pensions Committee hearing from March 10 in which they discussed the pharmaceutical cost supply chain. Presenters at the hearing included KPhA's Immediate Past President Matt Morrison, owner, Gibson's Pharmacy in Dodge City, and several representatives from PBMs.

  • 03/18/2021 12:35 PM | Anonymous member (Administrator)

    Pharmacists and Pharmacy Technicians alike have answered the call for certified immunizers to take on the monumental task of inoculating the public with the COVID-19 and other vaccines. KPhA has offered a series of trainings since January to prepare these providers for the task.

    Twenty-six pharmacists enrolled in the APhA Pharmacy-Based Immunization Delivery course offered by KPhA on March 6 and taught by Joshua Kinsey, PharmD, of Balls Foods Stores, and Jessica Bates, PharmD, BCPS, from the KU School of Pharmacy. The course featured a mix of home-study, live training and technique evaluations. Another 44 pharmacists particpated in a series of immunization refresher courses in January and February that met the training requirements outlined in HHS's Cares Act Amendment allowing pharmacists to give the COVID vaccine and other childhood vaccinations to those between the ages of 3 and 12. Those classes were taught by Amanda Applegate, PharmD, BCACP, from Balls Food Stores in Kansas City, KS; Mara Goebel, PharmD, from Gibson's Pharmacy in Dodge City; and Bates.

    More than 200 pharmacy technicians have become certified immunizers through KPhA training created by Lawrence Davidow, PhD, RPh, from the KU School of Pharmacy. One hundred twenty-nine technicians completed the requirements for the January classes, while 56 did so for the February class. Tweenty-two of 29 technicians have completed requirements after attending the March class.

    KPhA will offer an additional technician training course on at 1 p.m. on April 10. Registration is open at https://ksrx.org/event-4223401

  • 03/17/2021 10:11 AM | Anonymous member (Administrator)

    The following update was provided to the KPhA Board of Directors by 1861 Consulting on pharmacy-related topics for the board's March 11 meeting:

    PBM Licensure, Enhanced Regulation (SB 244 / HB 2383)
    SB 244 and HB 2383 would require licensure of pharmacy benefits managers and their enhanced regulation. Neither bill is scheduled for a hearing or exempted from deadlines.

    Point of Care Test & Treat (SB 200 / HB 2385)
    HB 2385 and SB 200 would allow a pharmacist to test and initiate therapy for a health condition that is generally managed with minimal treatment including, but not limited to: Influenza, streptococcus, COVID-19, pre-exposure prophylaxis, post-exposure prophylaxis, and other CLIA waived tests. On February 25th the Senate Health Committee heard proponent testimony speaking to issues surrounding access to care, breadth of pharmacists education, and how other states have adopted similar provisions. Opponent testimony raised concerns about the need for a physician-led care team, possibility of care fragmentation, and broad nature of the bill language lacking physician involvement. Following the hearing, the Committee Chair recommended conferees work together to come to an agreement.

    Reimbursement for Pharmacist Services (HB 2388)
    HB 2388 would require insurers that provide coverage of a professional service provided by a physician, APRN, or a PA also provide coverage for such services if lawfully provided by a pharmacist. This bill has not been scheduled for a hearing or exempted from deadlines.

    Board of Pharmacy Authority, Telepharmacy (SB 251 / HB 2280)
    HB 2280 and SB 251 would amend the Board of Pharmacy's regulatory and investigative authority, allow for telepharmacy in Kansas, and a series of other technical updates. SB 251 is exempted from deadlines while the House approved HB 2280 on a vote of 116-8 on March 3rd.

    PMP Updates, Integration Fees (SB 168 / HB 2253)
    HB 2253 and SB 168 would provide a series of updates to Kansas’ prescription drug monitoring program (K-TRACS), allow the Board of Pharmacy to adopt regulations necessary to establish a fee for integration into an electronic health record/pharmacy management system, access by delegates/researchers, and allow for a medical care facility to request deidentified program data. Neither bill has been scheduled for a hearing, however both are exempt from deadlines.

    State Budget (HB 2396 / HB 2397 / SB 267 / SB 268)
    The FY 2022 $20.9B Budget plan currently includes, but is not limited to, maintenance of school funding; reamortization of state employees retirement fund, Medicaid Expansion, a digital product tax, a marketplace facilitator tax, pay raise for state employees, a reduced sweep of transportation funding, and technology improvements for the State. Kansas Legislation requires a 7.5% SGF ending balance. The Governor’s main budget bills are HB 2397 & SB 267 and supplemental budget bills are HB 2396 & SB 268.

    Upcoming Deadlines
    Friday, March 5 – Deadline for consideration of bills in House of Origin (Turnaround Day) March 6 through March 9 – No Session Friday, March 26 – Last Day Non-Exempt Committee Consideration Wednesday, March 31 – Deadline for consideration of bills in 2nd House (On floor all day the entire week) April 1 - April 5 – No Session Friday, April 9 – First Adjournment Monday, May 1 – Veto Session Begins

    Senator Bob Dole Cancer Diagnosis
    Bob Dole, former United States Senator of Kansas and 1996 Republican Presidential nominee, announced that he has been diagnosed with stage 4 lung cancer. He served the public for decades; elected first to the U.S. Congress, Dole began his first term in the Senate in 1969 where he served until 1996. Dole, 96, said in a statement that he will start treatment next week.

  • 03/07/2021 2:22 PM | Anonymous member (Administrator)

    A research team from Purdue University, The Ohio State University, and Indiana University is seeking participants in an online survey and focus group for a study on Scope of Practice. The study, Determining and Regulating Scope of Practice, aims to address inefficiencies to make sure patients receive the highest quality care and have the best possible access to care.

    The research team is looking for a variety of stakeholders, including physicians; nurse practitioners; physician assistants; pharmacists; board of medicine, nursing, or pharmacy members; leaders in state or national medical, nursing, or pharmacy associations; healthcare administrators; pharmacy executives; and state or federal legislators. Those interested in signing up to participate need to do so by April 1.

    Study Title: Determining and Regulating Scope of Practice
    IRB# IRB-2020-1513

    Scope of practice, or what patient care services healthcare professionals are permitted to provide, does not always align with healthcare professionals’ skills and training, and scope of practice within one healthcare profession, as well as the process for determining scope, can vary widely between states. To address these inefficiencies and make sure patients receive the highest quality care and have the best possible access to care, we want to know:

    How do YOU think physician, nurse practitioner, physician assistant, and pharmacist scopes of practice should be determined and regulated?

    A research team from Purdue University, The Ohio State University, and Indiana University is conducting a study and ask that you participate in an online survey and focus group, likely to be held in April or May 2021. Participants will be able to remain anonymous in the virtual focus group by not turning on video and using the anonymous, unique participant ID that will be provided to you. The first 60 participants to a) participate in a focus group, AND b) complete the follow-up survey will receive a $49.99 Amazon e-gift card. If you would like for your voice to be heard, please follow this link to learn more and sign-up to participate: https://purdue.ca1.qualtrics.com/jfe/form/SV_b1qKVwhZP8Ya6hf

    Please sign-up by Thursday, April 1, 2021.

    For any questions, please contact:
    Principal Investigator: Dr. Kim Illingworth Plake, Purdue University
    Dr. Jenny Beal, Purdue University
    Dr. E. Michael Murphy, The Ohio State University

  • 02/10/2021 2:00 PM | Anonymous member (Administrator)

    Insulin continues to be one the most targeted medication for audits. Having an insulin prescription with a sliding scale attached can be easy prey for auditors. Anytime there is a sliding scale on insulin, a daily maximum number of units must be on the prescription in order to calculate an accurate days’ supply. Let us look at a few examples of some written instructions that an auditor could flag:

    1. Use as Directed
    2. Per Sliding Scale
    3. Inject 30 units in the morning, 20 units at night and as per sliding scale
      • Auditor will not assume maximum daily dose is 50 units
    4. Inject 35 units once daily. If blood sugar greater than 130, increase by 3 units every three days until lower than 130
      • Auditor will not assume maximum daily dose is 35 units

    PAAS Tips:

    • Call the doctor’s office to obtain an estimated maximum number of units per day when the instructions are written for “use as directed” or anytime a sliding scale is attached
      • Document a clinical note on the hard copy (who you spoke with and their title, date and time, maximum number of units clarified and your initials)
    • Clarify the maximum number of units per day prior to the first fill
      • Be sure to include the maximum daily dose on the patient label
      • PBMs may mark the prescription discrepant if the directions are not on the patient label or clarified after dispensing
    • You must obtain a maximum number of units per day even if you are dispensing the smallest package size (i.e. 1 vial or 1 box of insulin pens)

    PAAS National® is committed to serving community pharmacies and helping keep hard-earned money where it belongs. Contact us today at (608) 873-1342 or info@paasnational.com to see why membership might be right for you.

    By Trenton Thiede, PharmD, MBA, President at PAAS National®, expert third party audit advice and FWA/HIPAA compliance.

    © 2021  PAAS  National®  All Rights Reserved

  • 01/25/2021 2:54 PM | Anonymous member (Administrator)

    Association members will have the opportunity to become Certified MedWise Advisors™ to enhance patient care and establish Value-Based Payer Agreements

    Learn how during Product Theater sessions on Feb. 4 or Feb. 10

    Kansas Pharmacists Association (KPhA) is pleased to announce it has signed an agreement with Tabula Rasa HealthCare, Inc. (“TRHC”), a healthcare technology company advancing safer use of medications, to educate members on TRHC’s medication safety software, MedWise™. The partnership will develop medication safety programming and promote the opportunity for pharmacists to become Certified MedWise Advisors™, expanding the skillset to enhance patient outcomes and reduce overall costs.

    KPHA’s purpose and mission is dedicated to the advancement and promotion of quality and rational public health, with particular reference to assuring optimal pharmacotherapy for the citizens of Kansas. The Association is founded upon its commitment to preserve, protect, and advance the interests of, and to serve the economic, educational, ethical, and social needs of the pharmacy profession. 

    “This partnership exemplifies our mission to promote and protect the role of pharmacists as the medication expert in patient care relationships, and as an integral part of the health care team,” said KPHA Executive Director Aaron Dunkel. “ We look forward to collaborating with TRHC to bring awareness of polypharmacy and place MedWise in the hands of as many pharmacists in Kansas as we can.”

    MedWise’s ability to create a simultaneous, multi-drug analysis identifies patients who are at high risk for adverse drug events. With this information, pharmacists can provide personalized medication management for the patient, a game-changer for pharmacy practice.

    “TRHC is proud to partner with KPHA in creating awareness of the safe use of medication,” said TRHC President Orsula V. Knowlton, PharmD, MBA.  “A primary role of pharmacists in the community is to promote patient wellness and safety.  Through the broad use of MedWise, we are preparing Kansas pharmacists, today, and for the post-COVID-19 future.  Our systems support pharmacists as they continue to be sought-after for direct care, including the management of complex medication regimens to optimize outcomes and reduce total costs.”

    As part of the initiative, TRHC will be hosting exclusive Product Theater sessions to educate members on this revolutionary technology and learn how it can be leveraged to improve patient outcomes and reduce overall healthcare costs. Register today!

    Learn More: https://blog.prescribewellness.com/mds-pharmacy-association/

    About Tabula Rasa HealthCare
    Tabula Rasa HealthCare (TRHC) provides medication safety solutions empowering healthcare professionals to optimize medication regimens and reduce medication-related risk, specifically targeting adverse drug events. Utilizing its proprietary medication decision science technology, MedWise™, TRHC improves patient outcomes, reduces hospitalizations, and lowers healthcare costs. Additionally, TRHC provides an extensive clinical telepharmacy network across the U.S. Its solutions are trusted by health plans and pharmacies nationwide to help drive value-based payment results. For more information, visit TRHC.com.

KPhA appreciates the generous support provided by

Kansas Pharmacists

Preserving, protecting and advancing Kansas pharmacy practice through education, engagement and advocacy.

Contact Us

  • 1020 SW Fairlawn Road
    Topeka, KS 66604
  • 785.228.2327
  • info@ksrx.org
Powered by Wild Apricot Membership Software